TABLE 2.
Treatment | Protein (mg) | Activityb
|
Activity (U · mg−1) in the presence of c:
|
||
---|---|---|---|---|---|
U | U · mg−1 | DCCD (100 μM) | Na azide (1 mM) | ||
None | 9.40 | 0.800 | 0.085 | 0.045 | 0.024 |
Membrane + DM | |||||
Residual membrane | 4.39 | 0.108 | 0.024 | 0.020 | 0.019 |
Extracts (F1Fo) | 5.24 | 1.198 | 0.228 | 0.125 | 0.073 |
Membrane + EDTA | |||||
Residual membrane | 7.32 | 0.240 | 0.033 | 0.022 | 0.020 |
Extracts (F1) | 2.22 | 0.942 | 0.424 | 0.330 | 0.135 |
For solubilization of F1Fo, washed membranes (2 mg/ml) were suspended in TMG buffer containing Na ATP (1 mM), DM (1% [wt/vol]), and PMSF (0.1 mM); the suspension was incubated on ice for 1 h and centrifuged at 100,000 × g for 1 h. The supernatant containing soluble F1Fo was collected, and the pellet containing residual membranes was washed and resuspended in TMG buffer. For solubilization of F1, washed membranes (1 mg/ml) were subjected to similar treatments, except that the membranes were suspended in 100 mM Tris-HCl (pH 8.0)-15 mM EDTA-2 mM LiCl-1 mM ATP. EDTA was removed from the extracts by dialysis against TMG buffer containing 1 mM Na ATP. The pellet containing residual membranes was washed and resuspended in TMG buffer. ATPase assays were done with Na ATP (2 mM) as a substrate.
One unit of activity is defined as 1 μmol of P1 released per min.
DCCD or Na azide was added to assay mixtures, which were incubated at 37°C for 10 min prior to the start of ATPase assays by the addition of ATP.